COMMUNIQUÉS West-GlobeNewswire

argenx reports positive topline results from Phase 2 proof-of-concept trial of efgartigimod in primary immune thrombocytopenia
17/09/2018
Favorable safety and tolerability consistent with efgartigimod clinical trials to date Clinically meaningful platelet count improvements showed clear separation from placebo at increasing response thresholds Plan to [...]
BeiGene Announces Oral Data Presentations at Annual Meeting of the Chinese Society of Clinical Oncology
17/09/2018
BEIJING, China and CAMBRIDGE, Mass., Sept. 16, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative [...]
VBI Vaccines Responds to Unfounded Allegations in Globes Article
16/09/2018
CAMBRIDGE, Mass., Sept. 16, 2018 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (NASDAQ: VBIV) (“VBI”, the “Company”) is the subject of an article published in Globes, Israel business news, on September 12, 2018, written by Gali [...]
VBI Vaccines Responds to Unfounded Allegations in Globes Article
16/09/2018
CAMBRIDGE, Mass., Sept. 16, 2018 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (NASDAQ: VBIV) (“VBI”, the “Company”) is the subject of an article published in Globes, Israel business news, on September 12, 2018, written by Gali [...]
Kiniksa Presents KPL-716 Clinical Data at the 27th European Academy of Dermatology and Venereology
15/09/2018
- Single-doses were well-tolerated and showed reduction in pruritus - - Data support plans for advancement into multiple chronic pruritic diseases, including prurigo nodularis - HAMILTON, BERMUDA, Sept. 15, 2018 (GLOBE [...]
Sanofi: Positive Phase 3 results presented for Dupixent® (dupilumab)
15/09/2018
Positive Phase 3 results presented for Dupixent ® (dupilumab) show significant improvement on multiple measures of disease severity in adolescents with moderate-to-severe atopic dermatitis Results on skin clearing, itch [...]
Sanofi : Les résultats positifs de phase III concernant Dupixent® (dupilumab)
15/09/2018
Les résultats positifs de phase III concernant Dupixent ® (dupilumab) montrent une amélioration significative de plusieurs mesures de la sévérité de la maladie chez des adolescents atteints de dermatite atopique modérée [...]
Alder BioPharmaceuticals® Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
14/09/2018
BOTHELL, Wash., Sept. 14, 2018 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (Nasdaq: ALDR), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today [...]
PUF Ventures Perfectly Positioned to Benefit from a Renewed Enthusiasm in the Canadian Cannabis Space
14/09/2018
VANCOUVER, British Columbia, Sept. 14, 2018 (GLOBE NEWSWIRE) -- Enthusiasm has returned to the legal cannabis space in Canada and PUF Ventures Inc. (CSE: PUF) (OTC: PUFXF), a late stage ACMPR license candidate, appears [...]
Rubius Therapeutics Added to Russell 2000 and 3000 Indexes
14/09/2018
CAMBRIDGE, Mass., Sept. 14, 2018 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq:RUBY), a biotechnology company pioneering the development of a new class of ready-to-use cellular therapies, today announced that [...]
Endocyte Announces Closing of Public Offering of Common Stock
14/09/2018
WEST LAFAYETTE, Ind., Sept. 14, 2018 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq Global Market:ECYT), a biopharmaceutical company developing targeted therapeutics for personalized cancer treatment, announced today the [...]
INSYS Therapeutics to Present at Janney Healthcare Conference
14/09/2018
PHOENIX, Sept. 14, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, announced today [...]
Ogilvy CommonHealth Worldwide’s Chris Cullmann named one of the most 100 inspiring leaders in healthcare marketing by PharmaVOICE
14/09/2018
PARSIPPANY, N.J., Sept. 14, 2018 (GLOBE NEWSWIRE) -- Ogilvy CommonHealth Worldwide ( www.ogilvychww.com ), a WPP Health & Wellness company (NYSE: WPP, www.wpp.com ), today announced Chris Cullmann, head of digital [...]
Sienna Announces September Dividend
14/09/2018
MARKHAM, Ontario, Sept. 14, 2018 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA) today announced a dividend of $0.0765 per common share of the Company (each, a “Common Share”) [...]
Nuvectra® Announces Closing of Follow-On Stock Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
14/09/2018
PLANO, Texas, Sept. 14, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today the closing of its underwritten follow-on public offering of 3,248,750 [...]
Major shareholder announcement
14/09/2018
Company Announcement 14 September 2018 Pursuant to section 30 of Consolidated Act no. 12 of 8 January 2018 on capital markets, as amended, NeuroSearch A/S ("NeuroSearch") hereby announces to have received a major [...]
Scythian Biosciences Announces Execution of Share Purchase Agreement with MMJ International Investments Inc., owner of Argentina-based ABP S.A.
14/09/2018
Execution of the Share Purchase Agreement is a Key Benchmark in Finalizing Previously Announced $193 Million Sale of Assets in Caribbean and Latin America Shares to be Received in Consideration for the Proposed Sale of [...]
Free Health Visits, Available Through Teladoc Health, to Residents Impacted by Hurricane Florence
14/09/2018
Residents and Those Displaced Can Call 855-756-8708 to Access Treatment for Non-Emergency Illnesses PURCHASE, NY, Sept. 14, 2018 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, is [...]
Aptinyx Presents Preclinical Data on NMDA Receptor Modulator NYX-2925 at the International Association for the Study of Pain’s 17th World Congress on Pain
14/09/2018
EVANSTON, Ill., Sept. 14, 2018 (GLOBE NEWSWIRE) -- Aptinyx Inc. (NASDAQ:APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, [...]

Pages